Devices and methods for in vitro modeling of metastatic cancer
AssigneeXylyx Bio, Inc.
InventorsJohn O'NEILL, Igal GERMANGUZ, Evelyn ARANDA, Jennifer XIONG, Natalia KISSEL, Alexandra NICHOLS, Drew DALY
Life of this patent
Estimating the term…
Loading patent…
AssigneeXylyx Bio, Inc.
InventorsJohn O'NEILL, Igal GERMANGUZ, Evelyn ARANDA, Jennifer XIONG, Natalia KISSEL, Alexandra NICHOLS, Drew DALY
Estimating the term…
A cell culture platform for modeling metastatic cancer is disclosed. The platform comprises one or more cell culture vessels comprising a plurality of compartments. Each compartment houses a substrate include a decellularized tissue-specific extracellular matrix derived from tissue of a different anatomical region. Each tissue-specific extracellular matrix comprises a homogenous mixture of macromolecule fragments including collagen, elastin, and glycosaminoglycan. A kit for culturing cells in biomimetic environments is also disclosed. The kit comprises a plurality of substrate precursors and at least one reagent. Each substrate precursor comprises a decellularized tissue-specific extracellular matrix derived from tissue of a different anatomical region. The tissue-specific extracellular matrix comprises a homogenous mixture of macromolecule fragments including collagen, elastin, and glycosaminoglycan. The reagent is configured to configured to convert each substrate precursor into a substrate adapted for culturing cells thereon. Methods of assessing a tumor-associated response of a cancer colony are also disclosed herein.
A cell culture platform for modeling metastatic cancer comprising:
-15. (canceled)
(canceled)
-47. (canceled)
A method of assessing a response of one or more cancer colonies to a drug, the method comprising:
-52. (canceled)
(canceled)
-60. (canceled)
A method of assessing cell migration of a primary cancer colony, the method comprising:
-73. (canceled)
Dependencies are inferred from the claim text.